Clinical trial
Cardiovascular Improvements With MV ASV Therapy in Heart Failure
NCT01953874
Study timeline
Study start (unknown)2013-12-01Date precision: month
Registry last updated2018-02-28
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Acute Decompensated Heart Failureunresolved
Sleep Disordered Breathingunresolved
Interventions
MV ASVDEVICE
Sponsors & collaborators
ResMedlead sponsor
ResMed Foundationcollaborator
Mapped research locations
ChicagoIllinois, United States1Los AngelesCalifornia, United States1PhiladelphiaPennsylvania, United States1BaltimoreMaryland, United States1St LouisMissouri, United States1SeattleWashington, United States1CincinnatiOhio, United States1DurhamNorth Carolina, United States1DenverColorado, United States1Kansas CityMissouri, United States1NorfolkVirginia, United States1HersheyPennsylvania, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT01953874 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.